Targeting the TRPM4 Channel for Neurologic Diseases: Opportunity and Challenge

Area of Science:

• Neuroscience
• Ion Channel Physiology
• Molecular Biology

Background:

• Transient Receptor Potential Melastatin 4 (TRPM4) is a unique monovalent cation channel.
• Abnormal TRPM4 activity is linked to various neurological disorders, including stroke, epilepsy, and neurodegenerative diseases.
• TRPM4 up-regulation contributes to neuronal and glial cell death following brain hypoxia/ischemia and inflammation.

Purpose of the Study:

• To review the pathophysiological roles of TRPM4 in neurological diseases.
• To discuss current TRPM4 inhibitors and their limitations.
• To highlight TRPM4 as a potential therapeutic target for neurological conditions.

Main Methods:

• Literature review of studies on TRPM4 function and inhibition.
• Analysis of TRPM4's role in neuronal injury and death.
• Examination of existing TRPM4 modulating agents.

Main Results:

• TRPM4 activation leads to ionic influx, cell swelling (oncosis), and membrane depolarization.
• TRPM4 contributes to excitotoxicity by interacting with NMDA receptors during hypoxia.
• TRPM4 expression is low in healthy neurons, making it a viable drug target.

Conclusions:

• TRPM4 plays a significant role in the pathophysiology of neurological disorders.
• Targeting TRPM4 presents a potential therapeutic avenue for treating neurological diseases.
• Further development of TRPM4 inhibitors is crucial for clinical translation.